Lucid Diagnostics Inc
Veridion Score
BETALOW CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is LUCD moving today?
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
LUCD overview
Related filings and maps
Congress activity in LUCD
No receipt-qualified Congressional disclosure is present for LUCD in the cached public ledger.
LUCD contract awards, year to date.
Public federal awards linked to this ticker.
LUCD lobbying filings, year to date.
Registered lobbying filings matched to Lucid Diagnostics Inc.